531 related articles for article (PubMed ID: 9568639)
1. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.
Seftor RE; Seftor EA; De Larco JE; Kleiner DE; Leferson J; Stetler-Stevenson WG; McNamara TF; Golub LM; Hendrix MJ
Clin Exp Metastasis; 1998 Apr; 16(3):217-25. PubMed ID: 9568639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
Lokeshwar BL; Selzer MG; Zhu BQ; Block NL; Golub LM
Int J Cancer; 2002 Mar; 98(2):297-309. PubMed ID: 11857423
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers.
Lokeshwar BL
Pharmacol Res; 2011 Feb; 63(2):146-50. PubMed ID: 21093590
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
5. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
Seftor EA; Seftor RE; Nieva DR; Hendrix MJ
Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131
[No Abstract] [Full Text] [Related]
6. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.
Lee HM; Golub LM; Cao J; Teronen O; Laitinen M; Salo T; Zucker S; Sorsa T
Curr Med Chem; 2001 Feb; 8(3):257-60. PubMed ID: 11172680
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes.
Uitto VJ; Firth JD; Nip L; Golub LM
Ann N Y Acad Sci; 1994 Sep; 732():140-51. PubMed ID: 7978787
[TBL] [Abstract][Full Text] [Related]
8. Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.
Meng Q; Xu J; Goldberg ID; Rosen EM; Greenwald RA; Fan S
Clin Exp Metastasis; 2000; 18(2):139-46. PubMed ID: 11235989
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro.
Myers SA; Wolowacz RG
Adv Dent Res; 1998 Nov; 12(2):86-93. PubMed ID: 9972128
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell invasiveness by chemically modified tetracyclines.
Gu Y; Lee HM; Roemer EJ; Musacchia L; Golub LM; Simon SR
Curr Med Chem; 2001 Feb; 8(3):261-70. PubMed ID: 11172681
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).
Lokeshwar BL; Escatel E; Zhu B
Curr Med Chem; 2001 Feb; 8(3):271-9. PubMed ID: 11172682
[TBL] [Abstract][Full Text] [Related]
13. Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells.
Bildt MM; Snoek-Van Beurden AM; DeGroot J; Van El B; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontal Res; 2006 Oct; 41(5):463-70. PubMed ID: 16953823
[TBL] [Abstract][Full Text] [Related]
14. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.
Jacob K; Wach F; Holzapfel U; Hein R; Lengyel E; Buettner R; Bosserhoff AK
Melanoma Res; 1998 Jun; 8(3):211-9. PubMed ID: 9664142
[TBL] [Abstract][Full Text] [Related]
15. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR
Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617
[TBL] [Abstract][Full Text] [Related]
17. The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration.
Mäkelä M; Sorsa T; Uitto VJ; Salo T; Teronen O; Larjava H
Adv Dent Res; 1998 Nov; 12(2):131-5. PubMed ID: 9972137
[TBL] [Abstract][Full Text] [Related]
18. MMP inhibition in prostate cancer.
Lokeshwar BL
Ann N Y Acad Sci; 1999 Jun; 878():271-89. PubMed ID: 10415736
[TBL] [Abstract][Full Text] [Related]
19. Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.
Llorens A; Vinyals A; Alia P; López-Barcons L; Gonzalez-Garrigues M; Fabra A
Mol Carcinog; 1997 May; 19(1):54-66. PubMed ID: 9180929
[TBL] [Abstract][Full Text] [Related]
20. The lipophilicity, pharmacokinetics, and cellular uptake of different chemically-modified tetracyclines (CMTs).
Liu Y; Ramamurthy N; Marecek J; Lee HM; Chen JL; Ryan ME; Rifkin BR; Golub LM
Curr Med Chem; 2001 Feb; 8(3):243-52. PubMed ID: 11172678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
